Hubei Jumpcan Pharmaceutical Co., Ltd.
600566
Helyezés a részvények között
#4335
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
Részvényárfolyam
$3.87
Piaci kapitalizáció
$3.57B
Változás (1 nap)
-1.64%
Változás (1 év)
9.08%
Ország
CN
Kereskedés Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Kategória
Healthcare
Hubei Jumpcan Pharmaceutical Co., Ltd. (600566) nyeresége
Nyereség ekkor: 2026 TTM: 0
Hubei Jumpcan Pharmaceutical Co., Ltd. legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi nyeresége 0. 2026 évben a vállalat 0 nyereséget ért el, megegyezik a 2026 év nyereségéhez, amely 0 volt. Az ezen az oldalon megjelenített nyereség a kamatok és adók előtti eredmény, azaz EBIT.
Hubei Jumpcan Pharmaceutical Co., Ltd. nyereségtörténete 2001 és 2026 között
Nyereség az év végén
| Év | Nyereség | Változtassa meg |
|---|---|---|
| 2025 | $309.05M | -24.26% |
| 2024 | $408.03M | -12.40% |
| 2023 | $465.78M | 28.11% |
| 2022 | $363.58M | 18.48% |
| 2021 | $306.87M | 35.13% |
| 2020 | $227.09M | -16.47% |
| 2019 | $271.87M | -5.40% |
| 2018 | $287.38M | 30.25% |
| 2017 | $220.64M | 40.80% |
| 2016 | $156.70M | 27.27% |
| 2015 | $123.13M | 26.13% |
| 2014 | $97.62M | 27.38% |
| 2013 | $76.64M | 66.50% |
| 2012 | $46.03M | 3,404.74% |
| 2011 | $1.31M | -0.73% |
| 2010 | $1.32M | 15.79% |
| 2009 | $1.14M | -13.96% |
| 2008 | $1.33M | -42.34% |
| 2007 | $2.30M | 28.76% |
| 2006 | $1.79M | 27.84% |
| 2005 | $1.40M | 13.48% |
| 2004 | $1.23M | -0.48% |
| 2003 | $1.24M | -50.58% |
| 2002 | $2.51M | -0.21% |
| 2001 | $2.51M | 0.00% |
Hasonló cégek vagy versenytársak nyeresége
| Vállalat | Nyereség | Nyereségkülönbség | Ország |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
